BG
EW icon

Berry Group’s Edwards Lifesciences EW Stock Holding History

Berry Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.08M Hold
11,814
– – 0.49% 46
2020
Q3 		$943K Hold
11,814
– – 0.51% 45
2020
Q2 		$816K Hold
11,814
– – 0.51% 45
2020
Q1 		$743K Sell
11,814
-843
-7% -$60.8K 0.56% 44
2019
Q4 		$984K Buy
+12,657
New +$988K 0.53% 43

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Berry Group's EW Position: Q4 2020 in Review

Berry Group held its Edwards Lifesciences (EW) position steady in Q4 2020 at 11,814 shares worth $1.08M. The position accounts for 0.49% of the portfolio, ranked #46.

Berry Group first reported a position in EW in Q4 2019 and has held it in 5 quarters since. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Berry Group held 11,814 shares of Edwards Lifesciences worth $1.08M as of Q4 2020.
  • Berry Group left its Edwards Lifesciences share count unchanged in Q4 2020.
  • Edwards Lifesciences made up 0.49% of Berry Group's portfolio in Q4 2020, its #46 holding.
  • Berry Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 5 quarters since.
  • 1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Berry Group's 13F filing for Q4 2020, filed 11 Feb 2021.